Coeptis Therapeutics to acquire cell therapies from Deverra Therapeutics


Wexford-based pharmaceutical company Coeptis Therapeutics Holdings Inc. saw its shares rise 10% Tuesday after it announced plans to acquire a cell therapy in phase one clinical trials.

Previous Colorado orgs get $30M to expand financial access
Next Pikes Peak summit builder accused by city of shoddy work at 14,000 feet